Anebulo Pharmaceuticals, Inc. stock is down -5.5% since 30 days ago. The next earnings date is Feb 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 November’s closed higher than October.
Anebulo Pharmaceuticals, Inc. engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. The company was incorporated in 2020 and is based in Lakeway, Texas.